US Equity

We explore whether the biotech rally can continue and if Gilead Sciences has bottomed.
More than three-quarters of the companies in the S&P 500 have reported results, and 66% have exceeded expectations.
There is someone else on the other side of our trades and they aren't the dupe or patsy we would like to believe.
Sprint has run up sharply on M&A hopes, and still isn't in great financial shape. That gives T-Mobile a lot of leverage.
Bears keep waiting for a Trumpian disaster.
The stock appears vulnerable to more declines.
More weakness lies ahead.
They are all now in play, until proved otherwise.
As the stock slips lower, the bears are running the table.
Choices permit a trader to tailor the situation to their comfort.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.